TrialAntimicrobial agents and chemotherapy1997

A study to determine the pharmacokinetics and inflammatory fluid penetration of two doses of a solid formulation of the hexetil prodrug of a trinem, sanfetrinem (GV 104326).

R Wise et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.